7-(3,5-Dimethylisoxazol-4-yl)-2-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one

ID: ALA4163057

Chembl Id: CHEMBL4163057

PubChem CID: 145959505

Max Phase: Preclinical

Molecular Formula: C19H16N2O3

Molecular Weight: 320.35

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1)C(=O)N2

Standard InChI:  InChI=1S/C19H16N2O3/c1-11-17(12(2)24-21-11)14-8-9-15-16(10-14)23-18(19(22)20-15)13-6-4-3-5-7-13/h3-10,18H,1-2H3,(H,20,22)

Standard InChI Key:  CFEPMQSRXBRVHM-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4163057

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 320.35

Molecular Weight (Monoisotopic): 320.1161

AlogP: 4.03

#Rotatable Bonds: 2

Polar Surface Area: 64.36

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.31

CX Basic pKa: 1.42

CX LogP: 3.03

CX LogD: 3.03

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.77

Np Likeness Score: -0.41

References

1. Xue X, Zhang Y, Wang C, Zhang M, Xiang Q, Wang J, Wang A, Li C, Zhang C, Zou L, Wang R, Wu S, Lu Y, Chen H, Ding K, Li G, Xu Y..  (2018)  Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer.,  152  [PMID:29758518] [10.1016/j.ejmech.2018.04.034]

Source

Source(1):

• Scientific Literature